Rhythm Biosciences Ltd
ASX:RHY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Rhythm Biosciences Ltd
ASX:RHY
|
AU |
Income Statement
Earnings Waterfall
Rhythm Biosciences Ltd
Income Statement
Rhythm Biosciences Ltd
| Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
-39%
|
0
-46%
|
0
-34%
|
0
-54%
|
0
-31%
|
0
+158%
|
0
+410%
|
3
+2 493%
|
0
-95%
|
2
+1 005%
|
3
+88%
|
3
+2%
|
2
-48%
|
|
| Gross Profit | |||||||||||||||
| Cost of Revenue |
(2)
|
(2)
|
(1)
|
(2)
|
(2)
|
(2)
|
(0)
|
(3)
|
(1)
|
(3)
|
(3)
|
(2)
|
(4)
|
(4)
|
|
| Gross Profit |
(1)
N/A
|
(1)
+0%
|
(1)
+8%
|
(1)
-10%
|
(2)
-46%
|
(2)
-11%
|
(0)
+93%
|
(3)
-1 530%
|
3
N/A
|
(3)
N/A
|
(1)
+70%
|
1
N/A
|
(0)
N/A
|
(3)
-683%
|
|
| Operating Income | |||||||||||||||
| Operating Expenses |
(2)
|
(2)
|
(3)
|
(4)
|
(6)
|
(9)
|
(11)
|
(8)
|
(11)
|
(5)
|
(3)
|
(3)
|
(3)
|
(4)
|
|
| Selling, General & Administrative |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(3)
|
(6)
|
(3)
|
(7)
|
(2)
|
(0)
|
(1)
|
(2)
|
(2)
|
|
| Research & Development |
(1)
|
(1)
|
(2)
|
(2)
|
(5)
|
(6)
|
(5)
|
(5)
|
(4)
|
(3)
|
(2)
|
(1)
|
(1)
|
(2)
|
|
| Depreciation & Amortization |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(4)
N/A
|
(4)
-4%
|
(4)
-10%
|
(5)
-27%
|
(8)
-48%
|
(11)
-45%
|
(11)
+0%
|
(11)
+2%
|
(8)
+25%
|
(8)
+7%
|
(4)
+50%
|
(2)
+47%
|
(4)
-78%
|
(7)
-82%
|
|
| Pre-Tax Income | |||||||||||||||
| Interest Income Expense |
0
|
0
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(3)
|
(3)
|
(0)
|
(0)
|
(0)
|
|
| Total Other Income |
1
|
1
|
0
|
1
|
1
|
2
|
2
|
3
|
0
|
2
|
2
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(3)
N/A
|
(3)
-17%
|
(4)
-35%
|
(4)
-2%
|
(7)
-61%
|
(9)
-33%
|
(9)
+0%
|
(8)
+6%
|
(8)
+0%
|
(9)
-5%
|
(7)
+21%
|
(2)
+68%
|
(4)
-76%
|
(7)
-74%
|
|
| Net Income | |||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(3)
|
(3)
|
(4)
|
(4)
|
(7)
|
(9)
|
(9)
|
(8)
|
(8)
|
(9)
|
(7)
|
(2)
|
(4)
|
(7)
|
|
| Net Income (Common) |
(3)
N/A
|
(3)
-17%
|
(4)
-35%
|
(4)
-2%
|
(7)
-61%
|
(9)
-33%
|
(9)
+0%
|
(8)
+6%
|
(8)
+0%
|
(9)
-5%
|
(7)
+21%
|
(2)
+68%
|
(4)
-76%
|
(7)
-74%
|
|
| EPS (Diluted) |
-0.02
N/A
|
-0.03
-50%
|
-0.04
-33%
|
-0.03
+25%
|
-0.03
N/A
|
-0.05
-67%
|
-0.04
+20%
|
-0.04
N/A
|
-0.04
N/A
|
-0.04
N/A
|
-0.03
+25%
|
-0.01
+67%
|
-0.01
N/A
|
-0.02
-100%
|
|